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Antioxidant supplementation is known to increase human endogenous antioxidant (AOX) capacity providing a
means of blunting exercise induced reactive oxygen species (ROS). The purpose of this study was to compare the
effects of a single acute dose of an AOX (vs blinded placebo) on muscle contractile performance and hormonal
responses to a single bout of lower limb ‘hypertrophic’ resistance training (RT). Fifteen resistance trained subjects
(age 23 ± 4 years: body mass 86 ± 6 kg) volunteered to participate in the study. Each subject attended the
laboratory on three occasions, firstly to determine three repetition maximum (3-RM) isotonic strength in the back
squat and perform a familiarisation of the experimental task. On the second/third visits subjects completed the
hypertrophic training session (HTS) which consisted of six sets of 10 repetitions of 70% of a predicted 1 RM load
(kg). Four hours prior to the HTS the subjects consumed 2 ml∙kg−1 total body mass of either the placebo mixture or
AOX supplement in a randomised order. Work completed during the strength training session was completed with
equipment that had an integrated linear force transducer (Gymaware system, Kinetic Performance Technology,
Canberra, Australia). During the placebo trials concentric mean power significantly (p < 0.05) decreased from sets
1–6. Accumulated power output during the AOX HTS was 6746 ± 5.9 W which was significantly greater compared
to the placebo HTS of 6493 ± 17.1 W (p < 0.05, ES’r = 0.99). Plasma growth hormone (GH) concentration was
significantly less immediately following AOX supplementation (6.65 ± 1.84 vs 16.08 ± 2.78 ng∙ml−1; p < 0.05, ES’r = 0.89).
This study demonstrates ingestion of an AOX cocktail prior to a single bout of resistance training improved muscle
contractile performance and modulated the GH response following completion of the resistance exercise. Future
studies should explore the mechanisms associated with the performance modification and specific muscle adaptations
to AOX supplementation in conjunction with heavy RT.
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Reactive oxygen species (ROS) have been implicated
as one of the causes of skeletal muscle fatigue during
both aerobic and anaerobic exercise [1]. Although small
increases in exercise induced ROS are important for
stimulating cellular growth and maximising muscular
force production [2,3], excessive accumulation leads to a
pro-oxidant environment which can damage DNA, lipid* Correspondence: david.bentley@adelaide.edu.au
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reproduction in any medium, provided the orand protein membranes [4,5]. Cellular damage may also
impair cross-bridge cycling during skeletal muscle con-
traction and accelerate the onset of fatigue [2,6,7]. This is
supported by previous work suggesting that a bout of re-
sistance training induces an excessive increase in ROS
production which could be implicated in the reduction in
skeletal muscle force generating capacity observed during
exercise [4,8,9].
To maximise gains in muscular hypertrophy an RT
session would typically involve exercising at a moderate
intensity, defined as lifting a load between 65-85% of an
individual’s one repetition maximum (RM), and using aral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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exercise [10]. Goldfarb and colleagues [8] found significant
increases in the plasma ROS markers malondialdehyde
(MDH) and protein carbonyls (PC) following arm flexor
exercise involving four sets of a 12 repetition maximum
(RM) load. Similar results have also been found for lower
body resistance exercise where plasma measures of oxi-
dised gluthanione (GSSG) and protein oxidation were ele-
vated following 30 min of sub-maximal squatting exercise
[4]. The primary cause of RT induced oxidative damage ap-
pears to result from increased xanthine and nicotinamide
adenine dinucleotide phosphate (NADPH) oxidase produc-
tion, together with ischemia–reperfusion which results in
an increase in xanthine oxidase (XO) and peroxynitrite
[9,11,12]. Xanthine oxidase production appears to be a pri-
mary cause of oxidative stress during vigorous exercise
[13], and plasma concentrations have been shown to in-
crease dramatically after performing an RT session [14].
Other sources such as a decrease in intracellular pH, lac-
tate accumulation and sarcomere disruption can also con-
tribute to RT induced ROS production [4,2].
It has been suggested that a supplementation regime
of antioxidants could reinforce the body’s endogenous
antioxidant system providing a means of blunting exer-
cise induced ROS molecules [15,16]. Several studies have
demonstrated that AOX supplementation can minimise
damage to cellular structures caused by RT [8,17] and
also help maintain muscular force [18] during isometric
maximal contractions. However, there are also a number
of studies that have found no benefit of AOX supple-
mentation on markers of oxidative stress or performance
[19-21]. Differing exercise protocols, subjects and types/
amounts of AOX supplements used, have been suggested
as the cause of the inconsistency between findings [21]. It
appears that RT protocols employing a higher volume and
intensity invokes the greatest oxidative stress response,
while there is some support for the effectiveness of Vita-
mins C and E and flavonoid supplements at attenuating
acute muscle injury in untrained individuals [21].
Most AOX studies have focused on the effects of vita-
min C and/or E supplementation to attenuate the oxida-
tive stress caused by RT [8,18-20]. There has been little
focus on plant polyphenols, which have potent antioxi-
dants qualities [22,23]. Pycnogenol (PYC) is a particularly
effective antioxidant polyphenol, comprised of several
proanthocyanidins and phenolic acids and has been
shown to blunt elevated ROS [24,25], increase growth
hormone (GH) secretion [26] and stimulate muscle blood
flow [27]. It has also previously been shown that the sup-
plement Lactaway©, containing PYC, acutely improves
endurance cycle performance without improving AOX
capacity [28,29]. There are no studies that have yet
assessed the effects of Lactaway© containing PYC on RT
performance and the associated bio-molecular responses.Hence, this study aimed to assess the effect of a PYC
mixture, on performance during lower limb ‘hyper-
trophic’ RT (HRT) and the resulting acute endocrine,
physiological and oxidative stress response.
Methods
Subjects
Fifteen healthy subjects volunteered to participate in the
study (age 23 ± 4 yr: body mass 86 ± 6 kg: height 179.4 ±
6.1 cm). Each subject had been resistance training for a
minimum of 2 yr prior to recruitment for the study. All
the subjects were familiar with the back squat exercise
(BS) and could perform the activity satisfactorily from a
technique perspective. Assessment was carried out by
the primary researcher who was a certified strength and
conditioning coach. Each subject completed a consent
form and pre activity screening questionnaire to identify
any musculoskeletal and orthopaedic problems that could
affect performance of the exercise. The study gained ap-
proval from the University of New South Wales, Human
Research Ethics Committee.
Study design
A double blind repeated measures design was employed
where the subjects ingested either the AOX treatment or a
placebo version prior to completing the training session. In
the 48 h leading up to these sessions the subjects were
instructed to refrain from intense physical exercise in order
to eliminate residual fatigue. The supplements were pro-
vided using a randomized and counterbalanced design.
The subjects visited the laboratory on three occasions,
firstly to record their physical characteristics and determine
their 3 RM BS which was used to predict 1RM strength
[1.06 × 3RM (kg) [30]]. On their second and third visits
subjects completed the hypertrophic training session
(HTS) which consisted of six sets of 70% of 1RM. The BS
was performed with an Olympic barbell using a power rack
(Body Maker, Nantong, China). The depth of the squat was
controlled by placing the safety spot inserts of the squat
rack device just below of the level the barbell when sub-
ject’s thighs were parallel to the ground. This acted as a
feedback mechanism for the participant and researcher but
participants were asked to refrain from “bouncing” on the
parallel bars. The subjects were instructed to refrain from
alcohol, foods with high AOX capacity and caffeine for
24 h prior to HTS. This information was in a document
which was read to each subject prior to commencement of
participation in the study. Subjects recorded their diet and
were asked to replicate the same dietary intake 24 hrs prior
to each session.
Preliminary measures and familiarisation
On the subjects’ first visit, their body mass (kg) was
measured using a balance beam (Weylux, England) and
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then undertook a warm on up on a cycle ergometer
(Schroberer Rad MeBtechnik (SRM), Weldorf, Germany),
cycling at 1 watt·kgˉ1 for five min. The determination of
the 3RM was followed according to methods previously
described [31]. Briefly, it required approximately four to
six sets to determine the 3RM with progressively heavier
loads per set. Three min rest was allowed between each
set and the 3RM was determined as the load lifted three
times and when no extra weight could be added. The
3RM was used to predict 1RM for each participant. After
a five min break a squat session of 10 repetitions at 70%
1RM load for five sets was performed.
Experimental procedures and supplements
Four hours prior to the HTS the subjects consumed
2 ml∙kg−1 body mass of either the placebo mixture or
AOX supplement [Lactaway©, Away Australia Pty Ltd,
Sydney, Australia] containing 2.4 g∙L of PYC in a rando-
mised order. The placebo and AOX mixtures tasted and
appeared the same. The participants and researchers
were not aware of which substance was supplement or
placebo until after the completion of the study when de-
tails were released by an independent person. The placebo
mixture contained the exact energy content (315 KJ) and
constituents (pineapple pulp, molasses, sodium chloride,
flavour, steviol glycosides, sodium benzoate, potassium
sorbate) as the Lactaway© mixture (315 KJ) but it did
not include any of the active AOX ingredient PYC.
After a brief cycling warm up, the subjects completed
a warm up set consisting of 10 repetitions at 50% of the
actual load to be used during the work sets. After a two
min rest period the subjects performed the second warm
up set at 80% of the load to be used during the work
sets. After a three min rest period, subjects com-
pleted six sets, separated by 2 min rest periods. The
subjects were instructed to lower the barbell under control
(eccentric) and then verbally encouraged to “drive” the
barbell upwards in as short as time possible (concentric).
The squat training session lasted ~18 min. After the com-
pletion of each set the subjects were also asked their rate
of perceived exertion (RPE) using the Borg scale [32]. Five
microliter (μL) finger tip capillary blood samples were
collected under standard aseptic procedures before, im-
mediately after and twenty min post-exercise to analyse
blood lactate (LT 1710 Lactate Pro, KDK Corporation,
Shiga, Japan).
An integrated linear force transducer (Gymaware system,
Kinetic Performance Technology, Canberra, Australia)
was used to determine barbell displacement for each
repetition and set completed. This system allows for the
determination of concentric mean power (W), and con-
centric velocity (m·s) to be determined. The system was
set up according to the manufacturer’s guidelines and hasbeen shown to provide a reliable (Coefficients of vari-
ation (CV) = 3.3%) and valid estimate of power during
resistance training [33].
Blood collection and analysis
Venous blood was withdrawn via venepuncture before,
immediately after and twenty min after the HTS. Blood
was collected from a vein in the cubital fossa in ethyl-
enediaminetetraacetic acid (EDTA) (10 ml tube) vacutai-
ners (BD367863, NJ, USA). The samples were then
centrifuged at 3000 rpm for 10 min, at 4°C. The plasma
top layer was placed into Eppendorf tubes (Oldenburg,
Germany) and snapped frozen and stored at −80°C until
analysis.
Plasma GH, an indicator of the anabolic hormonal mi-
lieu during RT [34] was determined pre-exercise, imme-
diately post-exercise and 20 min post-exercise. Plasma
GH was assayed by a radio-immunoassay using a com-
mercially available kit (human growth hormone ELISA
DSL-10-1900, Diagnostic Systems Laboratories, Webster,
USA). The assay was performed in duplicate as per the
instructions from DSL and determined the levels of the
22 kDa GH isoform. The CV was less than 7% for the
assays and the limit detection was 0.03 ng/ml.
Plasma cortisol (CORT) was measured as an indicator
of the catabolic hormonal environment during RT [34],
and was determined by a radio-immunoassay using a
commercially available kit (cortisol ELISA DSL-10-2000,
Diagnostic Systems Laboratories, Webster, USA). Plasma
CORT was assayed pre-exercise, immediately post-exercise
and 20 min post-exercise. The assay was performed in du-
plicate as per the instructions from DSL and the CV was
less than 10%.
Xanthine oxidase (XO) was measured because it is in-
volved in free radical production and its elevation contrib-
utes to oxidative stress [12,13]. The XO was assayed in
duplicate using a commercially available kit (Invitrogen,
Carlsbad, California, USA). Plasma was assayed pre-
exercise and immediately post-exercise. The XO stock
solution was used to construct a standard curve. The
standards and serum were pipetted into a high binding
enzyme immunoassay (Caymen Chemical Co. Ann Arbor,
MI USA) 96 well plate. The plasma samples were diluted 1
fold by the placement of a buffer solution, and the XO
reaction was started when a composition of amplex
red, horseradish peroxidase, hypoxanthine and buffer
solution was added to each well. The plate was incu-
bated at 37°C for 30 min and the absorbance was read
at 550 nm using a PolarStar Galaxy plate reader (BMG
Laboratory Technologies, Offenburg, Germany).
Statistical analysis
A two way repeated measures analysis of variance
(ANOVA) was used to evaluate changes over time and
Figure 2 Velocity (m.s) during each set of the resistance
training session (HTS) when AOX or placebo was ingested
(mean ± SEM). Statistically significant difference (*p < 0.05 and
**p < .001) between the AOX and placebo trials.
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GH, CORT and XO. If a significant F value was achieved
the Bonferroni post hoc test was performed. The level of
significance was set at p ≤ 0.05. All data was analysed
using SPSS for Windows version 16. Data are presented
as mean ± standard error of the mean (SEM). Where
relevant effect size ratios (ES’r) were calculated using
Cohens d [35]. An ES’r of ≥0.5 was considered to display
a moderate effect and ≥0.8 a large effect.
Results
The pre to post HTS, blood lactate concentrations
(Blac) increased significantly after both AOX supple-
mentation; 1.23 ± 0.08 to 7.68 ± 3.01 mmol.l−1 (p < 0.05)
and placebo supplementation; 1.79 ± 0.30 mmol.l−1 to
8.11 ± 2.98 mmol.l−1 (p < 0.05). Blood lactate continued
to be significantly elevated twenty min post-exercise for
both groups, but there was no significant difference in
Blac levels between the two conditions at any time point
(p > 0.05). The RPE was significantly increased in both
groups for sets three to six compared to set one. There
were however no significant differences in RPE between
the AOX and placebo conditions at any point during the
HTS (p < 0.05).
The concentric mean power and velocity are presented
in Figures 1 and 2 respectively. Following AOX supple-
mentation concentric mean power remained consistent
across all six sets of the HTS. However, during the pla-
cebo trials concentric mean power significantly decreased
from sets 1–6. During the placebo trial concentric mean
power was significantly lower in comparison to each set
in the AOX condition, with sets five and six having the
greatest decrease (p < 0.05, ES’r = 0.52). Similarly aver-
age velocity during the AOX was higher compared toFigure 1 Concentric power output for each set during the
resistance training session (HTS) when AOX or placebo was
ingested (mean ± SEM). Statistically significant difference (*p < 0.05
and **p < .001) between the AOX and placebo trials.placebo. Accumulated power output during the AOX
HTS was 6746 ± 5.9 W which was significantly greater
compared to the placebo HTS of 6493 ± 17.1 W (p < 0.05,
ES’r = 0.99).
The HTS resulted in a significantly elevated XO in
both the placebo (pre: 11.05 ± 0.94 to immediately post:
15.47 ± 1.11 mU.ml−1) and AOX condition’s (pre: 9.16 ±
0.93 to immediately post: 11.2 ± 2.48 mU.ml−1, p < 0.05).
The difference between the two conditions was not statis-
tically significant (p > 0.05). Circulating GH levels in-
creased significantly after both trials, however the increase
was significantly less immediately following AOX supple-
mentation; 6.65 ± 1.84 ng∙ml−1 compared to the placebo
trials;16.08 ± 2.78 ng∙ml−1 (p < 0.05, ES’r = 0.89). GH con-
tinued to be significantly elevated 20 min after the HTS
for both treatments, and was still significantly greater
following the placebo trial in comparison to the AOX
trial (p < 0.05) (Figure 3). Cortisol increased significantly
immediately after the HTS following AOX and placebo
supplementation to 567.25 ± 20.12 nmol∙l−1 and 571.43 ±
18.77 nmol∙l−1, respectively (p < 0.05). Cortisol was still
significantly elevated 20 min post exercise for both treat-
ments (p < 0.05) however there was no significant differ-
ence between the AOX and placebo HTS at any time point
(p < 0.05).
Discussion
The primary aim of the present research was to assess
the effect of a PYC mixture on performance during
lower limb ‘hypertrophic’ RT and the resulting acute
endocrine, physiological and oxidative stress response. It
was found that in comparison to a placebo mixture, sub-
jects were able to perform 3.75% more work (W), and
Figure 3 Growth hormone (GH) in response to the AOX and
placebo HTS (mean ± SEM). Statistically significant difference
(*p < 0.05 ) between the AOX and placebo trials.
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throughout the HTS after consuming the AOX mixture.
An additional aim was to establish the physiological,
endocrine and oxidative stress response to a HTS. There
were no significant differences between RPE, Blac, CORT
and XO between the two trials, however circulating GH
levels was significantly reduced in the AOX trial com-
pared to the placebo trial. This is the first study to dem-
onstrate that an AOX mixture containing PYC can
improve RT performance. There was a significant in-
crease in Blac levels immediately after both trials and
20 min post HTS from pre exercise values. The observed
increase was similar to other RT protocols using high
volume moderate loading intensity [36,37].
The attenuation of power decrement during the AOX
trial agrees with previous studies that have shown that
PYC AOX supplementation improves high intensity cyc-
ling and running performance [28,29]. This study was
unique in that performance was monitored for each
repetition and did not rely solely on the total volume for
the session. Instead, concentric performance was mea-
sured by mean power output. The key finding from the
performance data was that AOX supplementation was
effective in attenuating the decrease in mean power
which occurred in the placebo trial, meaning concentric
power output was greater during the AOX trial (see
Figure 1). During the placebo trial the mean power dec-
rements per set ranged from 5% to 10% (specific data not
shown). These observations are similar to the decrements
observed by Baker and Newton [38], however their study
employed a series of jump squats to elucidate a ROS re-
sponse, and therefore comparisons between the two stud-
ies should be approached with caution.The present study also found the oxidative stress re-
sponse as measured by the marker XO was significantly
increased after the HTS following both the placebo and
AOX trials. This is similar to other studies which also
observed an elevated XO response following strenuous
exercise [13,39]. The significant rise in XO would sug-
gest that the HTS in the present study invoked a sub-
stantial ROS response, which can lead to skeletal muscle
injury and fatigue [1,39,40]. Indeed, reduced XO activity
during RT has been linked to less oxidative damage and
enhanced recovery from RT sessions [13]. It was there-
fore hypothesised that the AOX treatment would blunt
the oxidative stress response, preserving skeletal muscle
integrity and force production when performing strenu-
ous RT such as BS exercise.
Yet, there was no significant difference in XO levels
between the placebo and AOX trials, although a slight
trend towards a reduction in XO following the AOX tri-
als was observed (p = 0.069). There was also no differ-
ence in blood lactate concentration between the two
conditions suggesting that differences in anaerobic fa-
tigue were not the cause for the disparity in perform-
ance. This data suggests other mechanisms of muscular
fatigue may have been involved in the performance
changes observed. One possible mechanism is a decrease
in Na+/K + ATPase pump activity [41]. A previous study
found AOX supplementation in the form of N-acetyl-
cysteine is effective in preserving Na+/K + ATPase activ-
ity during strenuous exercise, acting as a reduced thiol
donor and promoting the regeneration of the endogen-
ous AOX glutathione (GSH) [1,42]. Similarly, PYC sup-
plementation has been shown to enhance GSH activity
and decrease the levels of GSSG [43]. It is therefore
possible that in the present study, the PYC based AOX
supplement supported GSH levels which then lead to
decreased thiol oxidation thus maintaining Na+/K +
ATPase activity and attenuating muscular fatigue. An-
other possibility for the attenuation of muscular fatigue
during the AOX trial may be a result of nitric oxide
(NO) stimulated increased blood flow during exercise
[44]. It has been repeatedly shown that PYC can enhance
blood flow [23,25] and decrease platelet aggregation [45]
which can decrease peripheral blood flow to contracting
muscles during high intensity exercise [45]. At present it
can only be speculated that these mechanisms were in-
volved as GSH or muscular blood flow were not mea-
sured in this study. Further research with additional
measures of oxidative stress is required to help deter-
mine the precise mechanisms involved in the perform-
ance improvements observed.
Cortisol increased significantly in both groups after
the HTS and remained significantly elevated twenty min
post exercise. However, there was no significant differ-
ence between the two groups at any time. Previous
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of multiple set sessions with moderately high repeti-
tions increases CORT secretion [34,46]. The catabolic
activity of CORT may affect nitrogen balance after RT
which in turn may hinder strength and/or MH develop-
ment [47]. It would therefore be beneficial to attenuate
CORT secretion during and after RT to avoid the dele-
terious effects that may interfere with training adapta-
tions. At present, the effects of AOX supplementation
on attenuating CORT and the underlying biochemical
mechanisms involved is not well understood. Previous in-
vestigations with a similar design to the present study have
produced mixed results. One study found positive results,
where Vitamin C and E supplementation for 28 days sig-
nificantly reduced post exercise increases in CORT follow-
ing a lower body RT session. However, others agree with
the present study, finding that an AOX treatment failed to
mitigate the increase in CORT after a 90 min basketball
training session [48] and a 90 min intermittent shuttle
running protocol [49]. The discrepancy in results between
the studies could be due to the type and duration of exer-
cise sessions, and in particular the AOX supplementation
type and dosage. Additional research should focus on
using a greater dosage of PYC to further understand this
compounds effects on CORT.
The GH response to the HTS was significantly affected
by the AOX supplement. Immediately after the HTS the
AOX group had a significantly lower GH response com-
pared to the placebo group. This decreased circulating
GH was also evident in the AOX group 20 min post ex-
ercise. This finding was unexpected as previous research
showed PYC to be a potent secretagogue of GH in gen-
etically engineered cells [26]. That the opposite occurred
in this study is possibly related to the differing protocols
and test subjects between the two, considering their
findings were not observed in human subjects undertak-
ing RT as in the present study. Another possible explan-
ation is that GH secretion appears to be influenced by
the degree of skeletal muscular fatigue induced by an ex-
ercise protocol. It has been demonstrated how increasing
local muscular fatigue in the thigh by using forced exer-
cise repetitions significantly increased GH response [50].
It’s therefore possible that during the placebo trials par-
ticipants’ experienced greater levels of muscular fatigue,
as evidenced by the reduced mean power output com-
pared to the AOX trials, and thus leading to a greater
GH response. Further research is needed to help deter-
mine this possibility and the potential role AOX supple-
mentation has on GH secretion. Furthermore, as GH is
an anabolic hormone its elevation during RT coupled
with appropriate mechanical strain may be important for
the process of muscular hypertrophy [51,52]. This would
suggest that the GH results from this study indicate they
may be undesirable in regards to promoting muscularhypertrophy. It is therefore of interest for future studies
to examine whether this decreased circulating GH would
affect muscular hypertrophy after a prolonged period of
use or whether it acutely affects IGF-1 levels. Moreover,
recent research suggests excessive AOX supplementa-
tion may hinder important physiological training adapta-
tions [3,53]. This has prompted the suggestion that
optimal oxidant content for maximal force production
exists within the muscle [53]. These recent findings and
the GH results in this study, highlight the need to fur-
ther our understanding of the effect of AOX supplemen-
tation on training adaptations.
Conclusions
In conclusion, an acute dose of a PYC based AOX sup-
plement enhanced lower body RT performance in trained
males by improving mean concentric power, velocity and
total work output. The mechanisms involved are still un-
clear considering oxidative stress response (measured as
plasma XO) was not significantly reduced in the AOX
treatment, as hypothesised. Future studies should incorp-
orate further measures of oxidative stress, particularly
GSH, and muscle blood flow which may help determine
the biochemical and physiological mechanisms that led
to the results in this study. Furthermore, GH secretion
was significantly attenuated in the AOX trial compared
to the placebo. The mechanisms that led to these results
are not fully understood, but further research is required
as GH secretion is involved in MH and strength develop-
ment and its attenuation may negatively impact training
adaptations.
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